
Dekri teren
Estrikti chimik: S-63845
Nimewo CAS: 1799633-27-4

S-63845(S 63845;S63845)
Katalòg No.: URK-V734Itilize sèlman pou laboratwa.
S-63845 (S63845) is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM, with no appreciable binding affinity to BCL-2 or BCL-XL (Ki>10 UM).
Aktivite Byolojik
S-63845 (S63845) is a highly potent, selective Mcl-1 inhibitor with Kd of 0.19 nM, with no appreciable binding affinity to BCL-2 or BCL-XL (Ki>10 uM); mare nan renur BH3-lye Mcl-1, li ka touye selil kansè ki depann de MCL1-, ki gen ladan myelom miltip (IC50).<0.1 uM), leukaemia and lymphoma cells, by activating the BAX/BAK-dependent mitochondrial apoptotic pathway; is well tolerated and shopws high effectivity against mouse cancer models.
Kansè san
Preklinik
Pwopriyete fizikochimik
M.Wt |
829.259 |
|
Fòmil |
C39H37ClF4N6O6s |
|
Nimewo CAS |
1799633-27-4 |
|
Depo |
Solide poud -20 degre 3an; 4 degre 2 zan |
Nan Solvant -80 degre 6 Mwa -20 degre 1 Mwa |
Solibilite |
10 mM nan DMSO |
|
Non Chimik |
Dispiro[cyclohexane-1,2'-[2H]indene-1'(3'H),2''-[2H]imidazol]-4''-amine, {{11 }}metoksi-5''-metil-6'-[5-({1-propin-1-il)-3-piridinil]-, (1 ,1'R,4)- |
Referans
1. Kotschy A, et al. Lanati. 27 oktòb 2016;538(7626):477-482.
2. Merino D, et al. Sci Transl Med. 2017 Out 2;9(401). pii: eaam7049.
3. Letai A. Selil Kansè. 2016 Desanm 12;30(6):834-835.
Remak: Tout pwodwi Ureiko yo itilize sèlman pou rechèch syantifik oswa deklarasyon sètifika dwòg, epi nou pa bay pwodwi ak sèvis pou nenpòt itilizasyon pèsonèl!
Baj popilè: s63845 ka nimewo:1799633-27-4
Voye rechèch
Ou ka renmen tou